Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Potential consequences of high-dose infusion of ketamine for refractory status epilepticus: case reports and systematic literature review.

Golub D, Yanai A, Darzi K, Papadopoulos J, Kaufman B.

Anaesth Intensive Care. 2018 Sep;46(5):516-528. Review.

PMID:
30189827
2.

Ketamine continuous infusion for refractory status epilepticus in a patient with anticonvulsant hypersensitivity syndrome.

Esaian D, Joset D, Lazarovits C, Dugan PC, Fridman D.

Ann Pharmacother. 2013 Nov;47(11):1569-76. doi: 10.1177/1060028013505427. Epub 2013 Oct 9.

PMID:
24259603
3.

Ketamine for the treatment of refractory status epilepticus.

Fang Y, Wang X.

Seizure. 2015 Aug;30:14-20. doi: 10.1016/j.seizure.2015.05.010. Epub 2015 May 19. Review.

4.

Ketamine use in the treatment of refractory status epilepticus.

Synowiec AS, Singh DS, Yenugadhati V, Valeriano JP, Schramke CJ, Kelly KM.

Epilepsy Res. 2013 Jul;105(1-2):183-8. doi: 10.1016/j.eplepsyres.2013.01.007. Epub 2013 Jan 29.

PMID:
23369676
5.

NMDA antagonists for refractory seizures.

Zeiler FA, Teitelbaum J, Gillman LM, West M.

Neurocrit Care. 2014 Jun;20(3):502-13. doi: 10.1007/s12028-013-9939-6. Review.

PMID:
24519081
6.

Ketamine infusion for refractory status epilepticus: A case report of cardiac arrest.

Koffman L, Yan Yiu H, Farrokh S, Lewin J 3rd, Geocadin R, Ziai W.

J Clin Neurosci. 2018 Jan;47:149-151. doi: 10.1016/j.jocn.2017.10.044. Epub 2017 Oct 26.

PMID:
29107412
7.

Terminating prolonged refractory status epilepticus using ketamine.

Hsieh CY, Sung PS, Tsai JJ, Huang CW.

Clin Neuropharmacol. 2010 May;33(3):165-7. doi: 10.1097/WNF.0b013e3181d1e3cd.

PMID:
20098301
8.

Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study.

Gaspard N, Foreman B, Judd LM, Brenton JN, Nathan BR, McCoy BM, Al-Otaibi A, Kilbride R, Fernández IS, Mendoza L, Samuel S, Zakaria A, Kalamangalam GP, Legros B, Szaflarski JP, Loddenkemper T, Hahn CD, Goodkin HP, Claassen J, Hirsch LJ, Laroche SM.

Epilepsia. 2013 Aug;54(8):1498-503. doi: 10.1111/epi.12247. Epub 2013 Jun 12.

9.

Drug-induced EEG pattern predicts effectiveness of ketamine in treating refractory status epilepticus.

Basha MM, Alqallaf A, Shah AK.

Epilepsia. 2015 Apr;56(4):e44-8. doi: 10.1111/epi.12947. Epub 2015 Mar 11.

10.

(S)-Ketamine in Refractory and Super-Refractory Status Epilepticus: A Retrospective Study.

Höfler J, Rohracher A, Kalss G, Zimmermann G, Dobesberger J, Pilz G, Leitinger M, Kuchukhidze G, Butz K, Taylor A, Novak H, Trinka E.

CNS Drugs. 2016 Sep;30(9):869-76. doi: 10.1007/s40263-016-0371-2.

11.

Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review.

Claassen J, Hirsch LJ, Emerson RG, Mayer SA.

Epilepsia. 2002 Feb;43(2):146-53. Review.

12.

Refractory metabolic acidosis as a complication of high-dose midazolam infusion for pediatric status epilepticus.

Federman MD, Kelly R, Harrison RE.

Clin Neuropharmacol. 2009 Nov-Dec;32(6):340-1. doi: 10.1097/WNF.0b013e3181b77d07.

PMID:
19952873
13.

Intravenous ketamine in status epilepticus.

Höfler J, Trinka E.

Epilepsia. 2018 Oct;59 Suppl 2:198-206. doi: 10.1111/epi.14480. Epub 2018 Aug 26.

PMID:
30146731
14.

Early ketamine to treat refractory status epilepticus.

Kramer AH.

Neurocrit Care. 2012 Apr;16(2):299-305. doi: 10.1007/s12028-011-9668-7.

PMID:
22237581
15.

Efficacy and safety of ketamine in refractory status epilepticus in children.

Rosati A, L'Erario M, Ilvento L, Cecchi C, Pisano T, Mirabile L, Guerrini R.

Neurology. 2012 Dec 11;79(24):2355-8. doi: 10.1212/WNL.0b013e318278b685. Epub 2012 Nov 28.

PMID:
23197747
16.

Continuous infusion, general anesthesia and other intensive care treatment for uncontrolled status epilepticus.

Tasker RC, Vitali SH.

Curr Opin Pediatr. 2014 Dec;26(6):682-9. doi: 10.1097/MOP.0000000000000149. Review.

PMID:
25313975
17.

Early Use of the NMDA Receptor Antagonist Ketamine in Refractory and Superrefractory Status Epilepticus.

Zeiler FA.

Crit Care Res Pract. 2015;2015:831260. doi: 10.1155/2015/831260. Epub 2015 Jan 12. Review.

18.

Ketamine for refractory status epilepticus: a case of possible ketamine-induced neurotoxicity.

Ubogu EE, Sagar SM, Lerner AJ, Maddux BN, Suarez JI, Werz MA.

Epilepsy Behav. 2003 Feb;4(1):70-5.

PMID:
12609230
19.

Intensive care treatment of uncontrolled status epilepticus in children: systematic literature search of midazolam and anesthetic therapies*.

Wilkes R, Tasker RC.

Pediatr Crit Care Med. 2014 Sep;15(7):632-9. doi: 10.1097/PCC.0000000000000173. Review.

PMID:
24901802
20.

Lidocaine for status epilepticus in adults.

Zeiler FA, Zeiler KJ, Kazina CJ, Teitelbaum J, Gillman LM, West M.

Seizure. 2015 Sep;31:41-8. doi: 10.1016/j.seizure.2015.07.003. Epub 2015 Jul 13. Review.

Supplemental Content

Support Center